| Immunogenic effects of chemotherapy-induced tumor cell death YJ Wang, R Fletcher, J Yu, L Zhang Genes & diseases 5 (3), 194-203, 2018 | 253 | 2018 |
| Multidrug resistance proteins (MRPs) and cancer therapy YK Zhang, YJ Wang, P Gupta, ZS Chen The AAPS journal 17, 802-812, 2015 | 204 | 2015 |
| Repositioning of tyrosine kinase inhibitors as antagonists of ATP-binding cassette transporters in anticancer drug resistance YJ Wang, YK Zhang, RJ Kathawala, ZS Chen Cancers 6 (4), 1925-1952, 2014 | 77 | 2014 |
| Colorectal cancer prevention: immune modulation taking the stage R Fletcher, YJ Wang, RE Schoen, OJ Finn, J Yu, L Zhang Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1869 (2), 138-148, 2018 | 68 | 2018 |
| Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugs RJ Kathawala, YJ Wang, CR Ashby Jr, ZS Chen Chinese journal of cancer 33 (5), 223, 2014 | 67 | 2014 |
| Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: in vitro and in vivo study YJ Wang, YK Zhang, GN Zhang, SB Al Rihani, MN Wei, P Gupta, ... Cancer letters 396, 145-154, 2017 | 66 | 2017 |
| In vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1 H Zhang, A Patel, SL Ma, XJ Li, YK Zhang, PQ Yang, RJ Kathawala, ... British journal of pharmacology 171 (24), 5845-5857, 2014 | 65 | 2014 |
| Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transporters YK Zhang, GN Zhang, YJ Wang, BA Patel, TT Talele, DH Yang, ZS Chen Scientific reports 6 (1), 25694, 2016 | 63 | 2016 |
| Design and synthesis of human ABCB1 (P-glycoprotein) inhibitors by peptide coupling of diverse chemical scaffolds on carboxyl and amino termini of (S)-valine-derived thiazole … S Singh, NR Prasad, EE Chufan, BA Patel, YJ Wang, ZS Chen, ... Journal of Medicinal Chemistry 57 (10), 4058-4072, 2014 | 62 | 2014 |
| Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1 YJ Wang, RJ Kathawala, YK Zhang, A Patel, P Kumar, S Shukla, KL Fung, ... Biochemical pharmacology 90 (4), 367-378, 2014 | 61 | 2014 |
| Direct tumor killing and immunotherapy through anti-SerpinB9 therapy L Jiang, YJ Wang, J Zhao, M Uehara, Q Hou, V Kasinath, T Ichimura, ... Cell 183 (5), 1219-1233. e18, 2020 | 60 | 2020 |
| β-Elemene, a compound derived from Rhizoma zedoariae, reverses multidrug resistance mediated by the ABCB1 transporter HQ Guo, GN Zhang, YJ Wang, YK Zhang, K Sodani, TT Talele, CR Ashby, ... Oncology reports 31 (2), 858-866, 2014 | 59 | 2014 |
| Voruciclib, a potent CDK4/6 inhibitor, antagonizes ABCB1 and ABCG2-mediated multi-drug resistance in cancer cells P Gupta, YK Zhang, XY Zhang, YJ Wang, KW Lu, T Hall, R Peng, ... Cellular Physiology and Biochemistry 45 (4), 1515-1528, 2018 | 58 | 2018 |
| Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: in vitro and in vivo GN Zhang, YK Zhang, YJ Wang, P Gupta, CR Ashby Jr, S Alqahtani, ... Cancer letters 424, 19-29, 2018 | 54 | 2018 |
| Osimertinib (AZD9291), a mutant-selective EGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells XY Zhang, YK Zhang, YJ Wang, P Gupta, L Zeng, M Xu, XQ Wang, ... Molecules 21 (9), 1236, 2016 | 54 | 2016 |
| Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2 DS Wang, A Patel, S Shukla, YK Zhang, YJ Wang, RJ Kathawala, ... Oncotarget 5 (12), 4529, 2014 | 46 | 2014 |
| BET Inhibitors Potentiate Chemotherapy and Killing of SPOP-Mutant Colon Cancer Cells via Induction of DR5 X Tan, J Tong, YJ Wang, R Fletcher, RE Schoen, J Yu, L Shen, L Zhang Cancer research 79 (6), 1191-1203, 2019 | 42 | 2019 |
| Exploring naturally occurring ivy nanoparticles as an alternative biomaterial Y Huang, YJ Wang, Y Wang, S Yi, Z Fan, L Sun, D Lin, N Anreddy, H Zhu, ... Acta biomaterialia 25, 268-283, 2015 | 42 | 2015 |
| Semi-synthetic ocotillol analogues as selective ABCB1-mediated drug resistance reversal agents YK Zhang, H Zhang, GN Zhang, YJ Wang, RJ Kathawala, R Si, BA Patel, ... Oncotarget 6 (27), 24277, 2015 | 42 | 2015 |
| The BTK inhibitor ibrutinib (PCI-32765) overcomes paclitaxel resistance in ABCB1-and ABCC10-overexpressing cells and tumors H Zhang, A Patel, YJ Wang, YK Zhang, RJ Kathawala, LH Qiu, BA Patel, ... Molecular cancer therapeutics 16 (6), 1021-1030, 2017 | 38 | 2017 |
Zhe-Sheng ChenCollege of Pharmacy and Health Sciences, St. John's UniversityVerified email at stjohns.edu
